What is the efficacy of botulinum A toxin for treatment of benign essential blepharospasm (BEB)?

Updated: May 20, 2019
  • Author: Robert H Graham, MD; Chief Editor: Edsel Ing, MD, MPH, FRCSC  more...
  • Print
Answer

Chundury et al found that patients who preferred treatment with incotulinumtoxinA felt that it was more effective, while those who preferred treatment with onabotulinumtoxinA felt that it had a longer duration. [55]

However, Saad and Gourdeau found in a “split-face” technique study that no difference was noted in either subjective or objective measures between the two toxins. [56]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!